瓣膜置换术后应用左西孟坦的临床观察

发布时间：2018-04-11 23:31

本文选题：左西孟坦 + 瓣膜置换术　；参考：《中国现代医学杂志》2017年09期

【摘要】：目的观察左西孟坦在瓣膜置换术后应用的临床效果。方法二尖瓣置换术患者60例,随机分为常规治疗组和左西孟坦组,每组30例。术后常规治疗组给予强心、利尿等常规治疗,左西孟坦组在常规治疗组治疗基础上给予左西孟坦。比较两组患者治疗效果及恢复情况。结果术后左西孟坦组心肌损伤反应和呼吸机辅助时间与常规治疗组比较,差异有统计学意义(P0.05),左西孟坦组心肌损伤反应和呼吸机辅助时间减少;左西孟坦组重症加强护理病房(ICU)停留时间与常规治疗组比较,差异有统计学意义(P0.05),左西孟坦组ICU停留时间减少。结论左西孟坦用于心脏瓣膜置换术后患者可明显改善心功能,减轻心肌损伤反应,且不良反应少,值得临床推广。
[Abstract]:Objective to observe the clinical effect of levsimengtan after valvular replacement.Methods Sixty patients with mitral valve replacement were randomly divided into conventional treatment group and left West Montan group with 30 cases in each group.Postoperative routine treatment group was given cardiac, diuretic and other routine treatment, the left West Montan group on the basis of routine treatment group, levoximentam group.The curative effect and recovery were compared between the two groups.Results compared with the routine treatment group, the myocardial injury response and the ventilator assisted time in the left West Montan group were significantly different from those in the conventional treatment group (P 0.05), but the myocardial injury response and the ventilator assisted time in the left West Montan group were lower than those in the conventional treatment group.Compared with the routine treatment group, there was a significant difference between the left West Montan group and the routine treatment group (P 0.05). The ICU residence time in the left West Montan group was decreased.Conclusion Levamentam can significantly improve cardiac function and alleviate myocardial injury reaction after valvular replacement, and has less adverse reactions, so it is worth popularizing in clinic.
【作者单位】：中国人民解放军91中心医院心胸外科重症加强护理病房;郑州大学第一附属医院重症医学科;
【分类号】：R654.2

【相似文献】